Merkel Cell Carcinoma

The Merkel Cell Carcinoma (MCC) Patient Registry is a national multi-institutional collaborative effort that will prospectively follow and record outcomes and events in MCC patients. MCC is the prototypical rare tumor, and this registry will trail blaze new methodologies that will enable multiple investigators to examine real-world outcome data in real time.

Task Force Co-Chair David Miller Presents at MMIG Annual Meeting
Watch

David Miller, MD, co-chair of PDS' Merkel Cell Carcinoma Task Force, presented an overview of PDS' MCC Patient Registry during the Merkel Cell Multicenter Interest Group (MMIG) annual meeting on March 1, 2019, in Washington, D.C. Click the link at right to view Dr. Miller's spirited talk about the origins of the MCC Task Force and the dedicated individuals credited with making it happen.